title: [Clinical analysis of curative resection with hemihepatectomy for advanced hilar cholangiocarcinoma].
abstract: OBJECTIVE
  To investigate the superiority of curative resection with hemihepatectomy in treatment of hilar cholangiocarcinoma and the strategy to lower the incidence of complications and mortality.
  
  
  METHODS
  The clinical data of 50 patients with hilar cholangiocarcinoma who underwent surgical procedures in Peking University School of Oncology from January 1998 to May 2006 were retrospectively analyzed.
  
  
  RESULTS
  Forty-one patients (56.9%) underwent surgical resection. Twenty-two (53.6%) received a radical operation (RO). Thirty patients underwent preoperative percutaneous transhepatic cholangio-drainage (PTCD) to reduce the jaundice. Curative resection with hemihepatectomy was performed on 19 cases including 14 cases undergoing RO. Two patients who had undergone hemihepatectomy died of liver failure. The postoperative morbidity rate was 62% in all 50 cases, 78% in the hemihepatectomy group. The 1- and 2-year survival rates of the hemihepatectomy group were 57.1% and 27.3% respectively.
  
  
  CONCLUSIONS
  Curative resection with hemihepatectomy is a safe and effective option for hilar cholangiocarcinoma, especially for Bismuth III or IV type. Preoperative biliary drainage is necessary before a major hepatic resection.
authors.affiliation: Department of Surgery, Peking University School of Oncology, Beijing Cancer Hospital, Beijing, China.
authors.forename: Yi
authors.initials: Y
authors.lastname: Sun
authors.forename: Zhi-Yu
authors.initials: ZY
authors.lastname: Wu
authors.forename: Chun-Yi
authors.initials: CY
authors.lastname: Hao
authors.forename: Xin-Fu
authors.initials: XF
authors.lastname: Huang
authors.forename: Kun
authors.initials: K
authors.lastname: Wang
authors.forename: Quan
authors.initials: Q
authors.lastname: Bao
authors.forename: Hong-Gang
authors.initials: HG
authors.lastname: Qian
authors.forename: Bao-Cai
authors.initials: BC
authors.lastname: Xing
mesh_terms: D000328:Adult; D000368:Aged; D001650:Bile Duct Neoplasms / Q000473:pathology / Q000601:surgery*; D001653:Bile Ducts, Intrahepatic / Q000601:surgery*; D018281:Cholangiocarcinoma / Q000473:pathology / Q000601:surgery*; D005260:Female; D006498:Hepatectomy / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D016896:Treatment Outcome